SC 13D Filing

Company

Vistagen Therapeutics, Inc.

Filed

July 27, 2011

Accession Number

0001415889-11-000668

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →